title: Diabetes and cancer: a 2013 synopsis.
abstract: Diabetes, in particular type 2 diabetes, and cancer are two diseases that appear to be associated. Numerous epidemiological studies indicate indeed that diabetes increases the incidence of several tumors. Chronic hyperglycemia and/or insulin resistance with compensatory hyperinsulinemia could account for the association. On the other hand, the interpretation of the link between diabetes and cancer could be influenced by therapeutical interferences. Considering all these data together, cancer should be considered as a "new potential complication" of diabetes and integrated in the follow-up of diabetic subjects.
authors.affiliation: Université catholique de Louvain, Cliniques universitaires Saint-Luc, Avenue Hippocrate 54/UCL 5474, B-1200 Bruxelles, Belgium. Electronic address: martin.buysschaert@uclouvain.be.
authors.forename: M
authors.initials: M
authors.lastname: Buysschaert
authors.forename: S
authors.initials: S
authors.lastname: Sadikot
mesh_terms: D048909:Diabetes Complications / Q000097:blood / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000150:complications*; D006946:Hyperinsulinism / Q000097:blood / Q000150:complications*; D007004:Hypoglycemic Agents / Q000009:adverse effects; D007333:Insulin Resistance; D008297:Male; D009369:Neoplasms / Q000097:blood / Q000209:etiology* / Q000503:physiopathology; D009765:Obesity / Q000097:blood / Q000150:complications*; D012307:Risk Factors
chemical_list: D007004:Hypoglycemic Agents
keywords: Antihyperglycemic agents; Cancer; Diabetes; Hyperglycemia; Hyperinsulinemia